Meeting of the Advisory Council for the Elimination of Tuberculosis, 83688-83689 [2024-23885]

Download as PDF 83688 Federal Register / Vol. 89, No. 201 / Thursday, October 17, 2024 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Meeting of the Healthcare Infection Control Practices Advisory Committee Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention announces the following meeting for the Healthcare Infection Control Practices Advisory Committee (HICPAC). This virtual meeting is open to the public. DATES: The meeting will be held on November 14, 2024, from 9 a.m. to 5 p.m., EST, and November 15, 2024, 9 a.m. to 12 p.m., EST. ADDRESSES: The meeting will be webcast live via the World Wide Web. The webcast link can be found on the HICPAC website. https://www.cdc.gov/ hicpac/meeting.html FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., Program Analyst, HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE, Mailstop H16–3, Atlanta, Georgia 30329–4027, Telephone: (404) 718–8039; Email: hicpac@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion (DHQP), the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC; and the Secretary, Department of Health and Human Services, regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters to be Considered: The agenda will include the following updates: The Division of Health Quality Promotion Updates; Isolation Precautions Guideline Workgroup; the NHSN Neonatal Pediatric Definitions Update and the Healthcare Personnel Guideline Workgroup. Agenda items are subject to change. ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 18:31 Oct 16, 2024 Jkt 265001 Public Participation Oral Public Comment: This meeting will include time for members of the public to make an oral comment. Priority will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures below. All persons interested in making an oral public comment at the November 14–15, 2024, HICPAC meeting must submit a request between October 15, 2024, and October 25, 2024, at https:// www.cdc.gov/hicpac/meeting.html no later than 5 p.m., EDT, October 25, 2024, according to the instructions provided. If the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled time, CDC will conduct a lottery to determine the speakers for the scheduled public comment session. CDC staff will notify individuals regarding their request to speak by email by November 1, 2024. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–23896 Filed 10–16–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Meeting of the Advisory Council for the Elimination of Tuberculosis Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Council for the Elimination of Tuberculosis (ACET). This meeting is open to the public, limited only by the number of audio and web conference lines (1,000 lines are available). Time SUMMARY: PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 will be available for public comment (registration is required to provide oral comment; see the Oral Public Comment section below). DATES: The meeting will be held on December 3, 2024, from 9:30 a.m. to 4:30 p.m., EST, and December 4, 2024, from 10 a.m. to 12 p.m., EST. Written comments must be submitted by November 26, 2024. Registration to make oral comments must also be submitted by November 26, 2024. ADDRESSES: The public meeting will be held virtually through Zoom. Registration in advance is required to attend. Please visit https:// cdc.zoomgov.com/webinar/register/WN_ 1bRtm_1MRoiz83dFlQoHQQ to register. This registration for virtual attendance will remain open through the meeting. Prior to the meeting, each individual registrant will receive a registration confirmation along with an access link to the virtual meeting location. FOR FURTHER INFORMATION CONTACT: Marah Condit, M.S., Committee Management Lead, Office of Policy, Planning, and Partnerships, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US8–6, Atlanta, Georgia 30329–4027. Telephone: (404) 639–3423; Email: nchhstppolicy@ cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Advisory Council for the Elimination of Tuberculosis is charged with providing advice and recommendations regarding the elimination of tuberculosis (TB) to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, Centers for Disease Control and Prevention (CDC). Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; provides guidance and review on CDC’s Tuberculosis Prevention Research portfolio and program priorities; and reviews the extent to which progress has been made toward eliminating TB. Matters to be Considered: The agenda will include discussions on: (1) CDC’s National Center for HIV, Viral Hepatitis, STD, and TB Prevention Update; (2) CDC’s Division of Tuberculosis Elimination Update; (3) TB in New Arrivals; (4) CDC’s National Tuberculosis Surveillance System and Molecular Surveillance; (5) Tuberculosis Epidemiologic Studies Consortium III; (6) Think. Test. Treat TB Campaign; (7) Laboratory Developed Tests Workgroup Update; and (8) Drug E:\FR\FM\17OCN1.SGM 17OCN1 Federal Register / Vol. 89, No. 201 / Thursday, October 17, 2024 / Notices Shortage Workgroup Update. Agenda items are subject to change as priorities dictate. Public Participation Written Public Comment: Members of the public are welcome to submit written comments in advance of the meeting. Written comments must be submitted by emailing nchhstppolicy@ cdc.gov with subject line ‘‘ACET December 2024 Public Comment Registration’’ by November 26, 2024. Oral Public Comment: Individuals who would like to make an oral comment during the public comment period must register by emailing nchhstppolicy@cdc.gov with subject line ‘‘ACET December 2024 Public Comment Registration’’ by November 26, 2024. The public comment period is on December 4, 2024, at 10:15 a.m., EST. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–23885 Filed 10–16–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Meeting of the Board of Scientific Counselors, Office of Readiness and Response Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting for the Board of Scientific Counselors, Office of Readiness and Response (BSC, ORR). This is a virtual meeting and is open to the public, limited only by the number of web conference lines available (500 ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 18:31 Oct 16, 2024 Jkt 265001 lines). Time will be available for public comment. DATES: The meeting will be held on November 20, 2024, from 9:30 a.m. to 4:30 p.m., EST, and November 21, 2024, from 9 a.m. to 3 p.m., EST. ADDRESSES: Zoom virtual meeting. If you wish to attend the meeting, please register in advance by accessing the link at https://cdc.zoomgov.com/webinar/ register/WN_ sIWaL9XVRqWnBKMB2OO2wQ#/ registration. Instructions on accessing the meeting will be provided following registration. FOR FURTHER INFORMATION CONTACT: Dometa Ouisley, Public Health Analyst, Office of Science and Laboratory Readiness, Office of Readiness and Response, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H21–6, Atlanta, Georgia 30329–4027. Telephone: (404) 639– 7450; Email: DOuisley@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Board of Scientific Counselors, Office of Readiness and Response provides advice and guidance to the Secretary, Department of Health and Human Services (HHS); the Assistant Secretary for Health, HHS; the Director, Centers for Disease Control and Prevention (CDC); and the Director, Office of Readiness and Response (ORR), CDC. The Board recommends strategies and goals for readiness and response activities pertaining to programs and research within the agency and the ORR divisions and monitors the overall strategic direction and focus of the ORR divisions and offices. The Board may also perform second-level peer review of applications for grants-in-aid for research and research training activities, cooperative agreements, and research contract proposals relating to the broad areas within the center. For additional information about the Board, please visit https://www.cdc.gov/orr/scientificcounselors/. Matters to be Considered: Agenda topics for Day 1 of the meeting include ORR Updates, ORR Division Director Updates, CDC’s Response Readiness Framework, and a CDCReady Demonstration. Agenda topics for Day 2 include Poliovirus Containment Working Group Updates, ORR Science Agenda Working Group Updates, and Health Equity Working Group Updates. Agenda items are subject to change as priorities dictate. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 83689 Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–23926 Filed 10–16–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–3466–PN] Medicare and Medicaid Programs: Application From the American Association for Accreditation of Ambulatory Surgery Facilities dba QUAD A for Continued CMS-Approval of Its Outpatient Physical Therapy (OPT) Accreditation Program Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice with request for comment. AGENCY: This notice acknowledges the receipt of an application from the American Association for Accreditation of Ambulatory Surgery Facilities, dba QUAD A, for continued recognition as a national accrediting organization for outpatient physical therapy providers that wish to participate in the Medicare or Medicaid programs. DATES: To be assured consideration, comments must be received at one of the addresses provided below, no later than 5 p.m. on November 18, 2024. ADDRESSES: In commenting, refer to file code CMS–3466–PN. Because of staff and resource limitations, we cannot accept comments by facsimile (FAX) transmission. Comments, including mass comment submissions, must be submitted in one of the following three ways (please choose only one of the ways listed): 1. Electronically. You may submit electronic comments on this regulation to https://www.regulations.gov. Follow the ‘‘Submit a comment’’ instructions. 2. By regular mail. You may mail written comments to the following address ONLY: Centers for Medicare & Medicaid Services, Department of Health and Human Services, Attention: CMS–3466–PN, P.O. Box 8010, Baltimore, MD 21244–8010. SUMMARY: E:\FR\FM\17OCN1.SGM 17OCN1

Agencies

[Federal Register Volume 89, Number 201 (Thursday, October 17, 2024)]
[Notices]
[Pages 83688-83689]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23885]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting of the Advisory Council for the Elimination of 
Tuberculosis

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting of the Advisory Council for the Elimination of 
Tuberculosis (ACET). This meeting is open to the public, limited only 
by the number of audio and web conference lines (1,000 lines are 
available). Time will be available for public comment (registration is 
required to provide oral comment; see the Oral Public Comment section 
below).

DATES: The meeting will be held on December 3, 2024, from 9:30 a.m. to 
4:30 p.m., EST, and December 4, 2024, from 10 a.m. to 12 p.m., EST.
    Written comments must be submitted by November 26, 2024. 
Registration to make oral comments must also be submitted by November 
26, 2024.

ADDRESSES: The public meeting will be held virtually through Zoom. 
Registration in advance is required to attend. Please visit https://cdc.zoomgov.com/webinar/register/WN_1bRtm_1MRoiz83dFlQoHQQ to register. 
This registration for virtual attendance will remain open through the 
meeting. Prior to the meeting, each individual registrant will receive 
a registration confirmation along with an access link to the virtual 
meeting location.

FOR FURTHER INFORMATION CONTACT: Marah Condit, M.S., Committee 
Management Lead, Office of Policy, Planning, and Partnerships, National 
Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for 
Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US8-6, 
Atlanta, Georgia 30329-4027. Telephone: (404) 639-3423; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Advisory Council for the Elimination of Tuberculosis 
is charged with providing advice and recommendations regarding the 
elimination of tuberculosis (TB) to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, Centers 
for Disease Control and Prevention (CDC). Specifically, the Council 
makes recommendations regarding policies, strategies, objectives, and 
priorities; addresses the development and application of new 
technologies; provides guidance and review on CDC's Tuberculosis 
Prevention Research portfolio and program priorities; and reviews the 
extent to which progress has been made toward eliminating TB.
    Matters to be Considered: The agenda will include discussions on: 
(1) CDC's National Center for HIV, Viral Hepatitis, STD, and TB 
Prevention Update; (2) CDC's Division of Tuberculosis Elimination 
Update; (3) TB in New Arrivals; (4) CDC's National Tuberculosis 
Surveillance System and Molecular Surveillance; (5) Tuberculosis 
Epidemiologic Studies Consortium III; (6) Think. Test. Treat TB 
Campaign; (7) Laboratory Developed Tests Workgroup Update; and (8) Drug

[[Page 83689]]

Shortage Workgroup Update. Agenda items are subject to change as 
priorities dictate.

Public Participation

    Written Public Comment: Members of the public are welcome to submit 
written comments in advance of the meeting. Written comments must be 
submitted by emailing [email protected] with subject line ``ACET 
December 2024 Public Comment Registration'' by November 26, 2024.
    Oral Public Comment: Individuals who would like to make an oral 
comment during the public comment period must register by emailing 
[email protected] with subject line ``ACET December 2024 Public 
Comment Registration'' by November 26, 2024. The public comment period 
is on December 4, 2024, at 10:15 a.m., EST.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-23885 Filed 10-16-24; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.